NeuroSense Therapeutics Ltd

NASDAQ:NRSN  
1.18
+0.08 (+7.27%)
7:57:07 PM EDT: $1.15 -0.03 (-2.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NeuroSense Therapeutics Ltd Stock, NASDAQ:NRSN

11 HaMenofim Street, Building B, Herzliya, Tel Aviv 46725
Israel
Phone: +972.9.799.6183
Number of Employees: 18
http://www.neurosense-tx.com

Description

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer�s and Parkinson�s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.